CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-25 | Shah Gaurav President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −290,000 | 90,925 | ||
| 2020-02-10 | Schwartz Jonathan David Chief Medical Officer | Returned to the company · Stock Option (Right to Buy) | −213,101 | 38,309 | ||
| 2020-02-10 | Schwartz Jonathan David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2020-02-10 | Patel Kinnari Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-02-10 | Militello John | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2020-02-10 | Alam Kamran SVP - Finance & PFO | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2020-02-06 | Shah Gaurav President & CEO | Grant or award · Stock Option (Right to Buy) | +383,306 | 383,306 | ||
| 2020-02-06 | Schwartz Jonathan David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-02-06 | Patel Kinnari Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-02-06 | Militello John | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-02-06 | Alam Kamran SVP - Finance & PFO | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-12-10 | RTW INVESTMENTS, LP Director | Purchase | +225,000 | $22.25 | $5.0M | 17,282,324 |
| 2019-11-04 | Alam Kamran SVP - Finance & PFO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2019-09-02 | Schwartz Jonathan David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-09-02 | Patel Kinnari Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-09-02 | Militello John | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-04-16 | RTW INVESTMENTS, LP Director | Purchase | +550,005 | $17.50 | $9.6M | 17,057,324 |
| 2019-03-05 | Shah Gaurav Director | Sale | −25,000 | $16.90 | $423K | 686,950 |
| 2019-03-04 | Shah Gaurav Director | Sale | −24,900 | $17.28 | $430K | 711,950 |
| 2019-03-01 | Shah Gaurav Director | Sale | −25,000 | $17.34 | $434K | 736,850 |
Page 25 of 27 · 538 trades